David Cameron

Former UK prime minister David Cameron became a consultant for Illumina last month in order to help the company raise awareness about the benefits of genomics. Prior to his appointment, Cameron told the UK's Advisory Committee on Business Appointments that his main role would be to assist Illumina's engagement with foreign governments and stakeholders as it works and expands outside the UK, and that he would help with the formation of a new international advisory board and chair that board, which has not been established yet.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.